Back to Search Start Over

ICN shares off 23% on FDA's drug rejection

Authors :
Johnson, Greg
Source :
Los Angeles Times. Feb 18, 1995, Vol. v114, ppD1
Publication Year :
1995

Subjects

Subjects :
Valeant Pharmaceuticals International -- Securities
Virazole (Medication) -- Licensing agreements
Pharmaceutical industry -- Securities
Hepatitis C -- Drug therapy

Details

ISSN :
04583035
Volume :
v114
Database :
Gale General OneFile
Journal :
Los Angeles Times
Publication Type :
News
Accession number :
edsgcl.16546045

Tools

Authors Abstract Subjects Details